RAMM Pharma Profit Margin

RAMM Pharma (RAMMF) currently reports a profit margin of -715.57% as of July 2026. That compares with -350.49% in the prior-year period — down 104.2% year over year. That is below the sector sector average of 13.09%. Use the charts on this page to explore RAMM Pharma's profit margin history and peer comparisons.

RAMM Pharma's profit margin decreased from -350.49% to -715.57% — a 104.2% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RAMM Pharma's profit margin of -715.57% is lower than the its sector sector average of 13.09%. That is roughly 5567.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but RAMM Pharma's current -715.57% should be judged against industry norms (sector average: 13.09%) and against RAMMF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -715.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.09%. From there, open related valuation or income-statement pages for RAMM Pharma, and consider following RAMMF for alerts when major investors trade the stock.